746681
Last Update Posted: 2009-12-21
Recruiting has ended
Females accepted | 18 Years + |
188 Estimated Participants | No Expanded Access |
Interventional Study | Does not accept healthy volunteers |
Investigation of Tolterodine, Pregabalin and a Tolterodine - Pregabalin Combination for the Treatment of Overactive Bladder
Tolterodine is approved for use in the treatment of overactive bladder (OAB). The study is designed to a investigate whether pregabalin may have efficacy in OAB and whether the efficacy is altered when it is combined with tolterodine.
Eligibility
Relevant conditions:
Overactive Bladder
If you aren't sure if you meet the criteria above speak to your healthcare professional. Criteria may be updated but not reflected here, do not hesitate to contact the study if you think are close to fitting criteria.
locations
Data sourced from ClinicalTrials.gov